-
When a medical malpractice lawsuit is filed, the emergency physician (EP) and the hospital are often represented by the same defense counsel, but there are times when this is not in the EP's best interest, according to Robert B. Takla, MD, MBA, FACEP, chief of the Emergency Center at St. John Hospital and Medical Center in Detroit, MI.
-
Overcrowding and emergency department (ED) boarding are the two top liability risks that Douglas Brunette, MD, assistant chief of emergency medicine for clinical affairs at Hennepin County Medical Center in Minnesota, sees for EDs currently.
-
When Robert B. Takla, MD, MBA, FACEP, chief of the Emergency Center at St. John Hospital and Medical Center in Detroit, MI, was named in a lawsuit early in his career, he was certain he hadn't breached the standard of care, though the same may not have been true regarding one of his emergency physician (EP) colleagues.
-
Abdominal pain is an exceedingly common presentation in the emergency department. Every clinician fears missing the diagnosis of appendicitis. Children are particularly challenging since appendicitis is less common, and the history and physical may be subtle. The diagnostic use of CT is not without its risks and must be balanced against the potential risk of appendicitis in each individual patient. This article provides a comprehensive review of appendicitis in children.
-
If an ED patient dies because she doesn't take antibiotics, as instructed by the emergency physician (EP), this doesn't mean that her family won't later sue for medical malpractice.
-
Surgical removal of brain metastases remains an important part of palliative therapy for metastatic cancer.
-
Menstrually related migraine is difficult to treat and options are limited. Hormonal manipulation is controversial and unproven.
-
Teriflunomide, an orally administered inhibitor of dihydro-orotate dehydrogenase, was found to be superior to placebo in reducing relapses in a 2-year, Phase 3 clinical trial in patients with multiple sclerosis.
-
-
Forty-nine clinical centers and 18 positron emission tomography (PET) centers in the United States and Canada participated in a randomized, blinded-adjudication clinical treatment trial of 195 patients with symptomatic atherosclerotic internal carotid artery occlusion (AICAO) who also had hemodynamic cerebral ischemia identified by ipsilateral increased oxygen extraction fraction measured by PET.